Meiogenix is an agriculture biotech company that develops products based on Chromosome Editing. Meiogenix aims to unlock the natural genetic diversity of crops to expand biodiversity that can be used by farmers to address global climate, sustainability and food challenges.

Meiogenix

Meiogenix is a French biotech company that holds an exclusive and worldwide license for a technology that modulates the frequency of homologous recombination in eukaryotic cells. This technology facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties with commercial potential.

Biotechnology and Biological Sciences Research Council

Sofinnova Partners

Bpifrance

Casdin Capital

Genoa Ventures

Alexandria Venture Investments

Kurma Partners

AGORANOV

Meiogenix Hires Ricardo Garcia de Alba as CEO to Lead the Company through its Next Phase of Growth. https://lnkd.in/gDAU8-pi

We are looking for a talented technician to join our team, and help us change the future of plant breeding, genetics and agriculture !

MEIO

COM:MEIOGENIX

Meiogenix

locale

market

industry

website

linkedin

founding date

investor of

Metrics